Celularity Inc. Lease, Cost
Celularity Inc. (CELU) reported Lease, Cost of $5.42 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-04-30
- Celularity Inc. lease, cost for the quarter ending 2025-12-31 was $1.34M, a 3.08% increase year-over-year.
- Celularity Inc. lease, cost for the quarter ending 2025-09-30 was $1.32M, a 0.23% decline year-over-year.
- Celularity Inc. lease, cost for the quarter ending 2025-06-30 was $1.32M, a 2.09% increase year-over-year.
- Celularity Inc. lease, cost for the quarter ending 2025-03-31 was $1.44M, a 7.15% increase year-over-year.
- Celularity Inc. lease, cost for fiscal 2025 was $5.42M, a 3.06% increase from fiscal 2024.
- Celularity Inc. lease, cost for fiscal 2024 was $5.26M, a 119749.59% increase from fiscal 2023.
- Celularity Inc. lease, cost for fiscal 2023 was $4.39K, a 99.91% decline from fiscal 2022.
- Celularity Inc. lease, cost for fiscal 2022 was $4.64M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $2.66M derived: sum of 2 quarters · filed 2026-04-30 | $3.98M derived: sum of 3 quarters · filed 2026-04-30 | $5.42M 10-K · filed 2026-04-30 | |
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-14 | $2.64M derived: sum of 2 quarters · filed 2025-11-14 | $4.08M 10-Q · filed 2025-11-14 | $5.38M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-06-30 | $1.32M 10-Q · filed 2025-08-29 | $2.76M 10-Q · filed 2025-08-29 | $4.06M derived: sum of 3 quarters · filed 2026-04-30 | $5.38M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-03-31 | $1.44M 10-Q · filed 2025-08-29 | $2.74M derived: sum of 2 quarters · filed 2026-04-30 | $4.07M derived: sum of 3 quarters · filed 2026-04-30 | $5.36M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $2.63M derived: sum of 2 quarters · filed 2026-04-30 | $3.92M derived: sum of 3 quarters · filed 2026-04-30 | $5.26M 10-K · filed 2026-04-30 | $5.26K 10-K · filed 2025-05-08 |
| 2024-09-30 | $1.33M 10-Q · filed 2025-11-14 | $2.62M derived: sum of 2 quarters · filed 2025-11-14 | $3.96M 10-Q · filed 2025-11-14 | $774.39K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $1.29M 10-Q · filed 2025-08-29 | $2.63M 10-Q · filed 2025-08-29 | -$551.61K derived: sum of 3 quarters · filed 2025-08-29 | $527.39K derived: sum of 4 quarters · filed 2025-08-29 | |
| 2024-03-31 | $1.34M 10-Q · filed 2025-08-29 | -$1.84M derived: sum of 2 quarters · filed 2025-08-29 | -$762.61K derived: sum of 3 quarters · filed 2025-08-29 | $283.39K derived: sum of 4 quarters · filed 2025-08-29 | |
| 2023-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | -$2.11M derived: sum of 2 quarters · filed 2025-05-08 | -$1.06M derived: sum of 3 quarters · filed 2025-05-08 | $4.39K 10-K · filed 2025-05-08 | $4.39M 10-K · filed 2024-07-30 |
| 2023-09-30 | $1.08M 10-Q · filed 2024-12-06 | $2.13M derived: sum of 2 quarters · filed 2024-12-06 | $3.19M 10-Q · filed 2024-12-06 | $4.41M derived: sum of 4 quarters · filed 2024-12-06 | |
| 2023-06-30 | $1.05M 10-Q · filed 2024-11-07 | $2.11M 10-Q · filed 2024-11-07 | $3.33M derived: sum of 3 quarters · filed 2024-11-07 | $4.54M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-03-31 | $1.06M 10-Q · filed 2024-10-16 | $2.28M derived: sum of 2 quarters · filed 2024-10-16 | $3.49M derived: sum of 3 quarters · filed 2024-10-16 | $4.62M derived: sum of 4 quarters · filed 2024-10-16 | |
| 2022-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $2.42M derived: sum of 2 quarters · filed 2024-07-30 | $3.55M derived: sum of 3 quarters · filed 2024-07-30 | $4.64M 10-K · filed 2024-07-30 | |
| 2022-09-30 | $1.21M 10-Q · filed 2024-01-03 | $2.33M derived: sum of 2 quarters · filed 2024-01-03 | $3.42M 10-Q · filed 2024-01-03 | ||
| 2022-06-30 | $1.13M 10-Q · filed 2023-08-14 | $2.21M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $1.08M 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |